T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Zoom
ZM
$30.8B
| $97.2M | 0.01% |
+1,094,588
| New | +$90M |
|
652
Chewy
CHWY
$9.15B
| $97M | 0.01% |
+2,771,700
| New | +$93.6M |
|
653
Clorox
CLX
$12.8B
| $96.8M | 0.01% |
632,461
+51,252
| +9% | +$7.83M |
|
654
Gibraltar Industries
ROCK
$1.46B
| $96.5M | 0.01% |
2,390,684
+56,207
| +2% | +$2.18M |
|
655
WEX
WEX
$6.48B
| $96.3M | 0.01% |
462,721
-21,015
| -4% | -$4.23M |
|
|
INVX
656
Innovex International
INVX
$2.13B
| $96M | 0.01% |
1,999,413
-179,390
| -8% | -$7.8M |
|
657
Levi Strauss
LEVI
$8.64B
| $95.9M | 0.01% |
4,592,606
+1,392,606
| +44% | +$30.6M |
|
658
Raymond James Financial
RJF
$34.9B
| $95.6M | 0.01% |
1,696,898
-1,028,013
| -38% | -$58.6M |
|
|
CCMP
659
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $95.3M | 0.01% |
866,112
-20,783
| -2% | -$2.35M |
|
660
Grupo Aval
AVAL
$6.35B
| $95.1M | 0.01% |
11,926,293
-296,256
| -2% | -$2.26M |
|
661
Tractor Supply
TSCO
$19B
| $94.6M | 0.01% |
4,347,940
+351,335
| +9% | +$7.26M |
|
|
HPP
662
Hudson Pacific Properties
HPP
$777M
| $94.5M | 0.01% |
405,898
-19,026
| -4% | -$4.57M |
|
|
RDUS
663
DELISTED
Radius Health, Inc.
RDUS
| $94.4M | 0.01% |
3,875,313
+1,314,899
| +51% | +$28.7M |
|
664
Hope Bancorp
HOPE
$1.83B
| $94M | 0.01% |
6,822,006
+44,034
| +0.6% | +$601K |
|
665
MKS Inc
MKSI
$20.7B
| $93.8M | 0.01% |
1,204,128
-36,776
| -3% | -$3.11M |
|
666
NorthWestern Energy
NWE
$4.34B
| $93.7M | 0.01% |
1,299,330
-37,049
| -3% | -$2.63M |
|
|
XIFR
667
XPLR Infrastructure LP
XIFR
$1.08B
| $93.7M | 0.01% |
1,941,069
+667
| +0% | +$30.9K |
|
668
General Dynamics
GD
$107B
| $92.8M | 0.01% |
510,199
+2,423
| +0.5% | +$417K |
|
669
General Motors
GM
$76.1B
| $92.2M | 0.01% |
2,394,144
+7,412
| +0.3% | +$278K |
|
|
ONC
670
BeOne Medicines Ltd
ONC
$40.6B
| $91.8M | 0.01% |
740,447
-61,891
| -8% | -$7.86M |
|
|
IPHI
671
DELISTED
INPHI CORPORATION
IPHI
| $91.7M | 0.01% |
1,830,137
-370,229
| -17% | -$17.2M |
|
672
LCI Industries
LCII
$2.6B
| $91.5M | 0.01% |
1,017,136
-21,769
| -2% | -$1.92M |
|
|
CSW
673
CSW Industrials
CSW
$5.65B
| $91.5M | 0.01% |
1,341,994
-307,052
| -19% | -$19.2M |
|
674
FIVE9
FIVN
$2.33B
| $91.3M | 0.01% |
1,779,473
-53,041
| -3% | -$2.69M |
|
675
Paycom
PAYC
$9.52B
| $91.2M | 0.01% |
402,165
-39,696
| -9% | -$8.15M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.